Par Drugs and Chemicals Limited

NSE PAR.NS

Par Drugs and Chemicals Limited Shares (Diluted, Weighted) for the year ending March 31, 2024: 12,304,636

Par Drugs and Chemicals Limited Shares (Diluted, Weighted) is 12,304,636 for the year ending March 31, 2024, a 0.00% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Par Drugs and Chemicals Limited Shares (Diluted, Weighted) for the year ending March 31, 2023 was 12,304,636, a 0.00% change year over year.
Par Drugs and Chemicals Limited Shares (Diluted, Weighted) for the year ending March 31, 2022 was 12,304,636, a 100.00% change year over year.
Par Drugs and Chemicals Limited Shares (Diluted, Weighted) for the year ending March 31, 2021 was 6,152,318, a 0.00% change year over year.
Par Drugs and Chemicals Limited Shares (Diluted, Weighted) for the year ending March 31, 2020 was 6,152,318, a -50.00% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

NSE: PAR.NS

Par Drugs and Chemicals Limited

CEO	Mr. Jignesh Vallabhbhai Savani
IPO Date	May 30, 2019
Location	India
Headquarters	816, Nilamber Triumph
Employees	122
Sector	Materials
Industries Glass Chemicals & Advanced Materials Cleaning Supplies Composite Materials Cosmetics Personal Care Petrochemicals Plastics

Description

Par Drugs and Chemicals Limited develops, produces, and sells active pharma ingredients and fine chemicals in India. It offers magnesium salts, dried aluminum hydroxide gel, sodium aluminum silicate, precipitated silica, magnesium silicate, colloidal silicon dioxide, sucralfate USP, and amorphous and blended products. The company also exports its products. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.

Key trends

Past 5 years